Biblio Discovery — Demo Discovery Service

14,783 results

Showing 1–20 · 0.21 seconds · RSS

Journal

Pharmaceutics

Scopus

ISSN 1999-4923 · MDPI AG · 14,783 articles in the index

  1. Journal Article Full text

    New Properties of Supramolecular Complexes and Drug Nanoparticles

    Elena V. Uspenskaya; Anton V. Syroeshkin

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Supramolecular chemistry—is “the chemistry beyond the molecule bearing on the organized entities of higher complexity that result from the association of two or more chemical species held together by intermolecular forces”—J [...]

  2. Journal Article Full text

    Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer

    Taraneh Sadat Zavvar; Giulia Santo; Leonhard Gruber et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: Peptide receptor radionuclide therapy (PRRT) is an established treatment for neuroendocrine tumors (NETs), enabling targeted radiation delivery via radiolabeled peptides. Small cell lung cancer (SCLC) remains a major therapeutic challenge due to its aggressive nature and poor…

  3. Journal Article Full text

    Solid Microneedles from Poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate): A Solvent-Free, Biodegradable Platform for Drug Delivery

    Diana Araújo; Francisco Santos; Rui Igreja et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background: Solid microneedles (MNs) are effective transdermal delivery devices but are commonly fabricated from metallic or non-biodegradable materials, raising concerns related to sustainability, waste management, and processing constraints. This study aimed to evaluate the suitability of the…

  4. Journal Article Full text

    Peripheral Analgesic Effect of a Novel Curcuminoid Derivative: Possible Involvement of Peripheral Opioid Receptor and ATP-Sensitive Potassium Ion Channel

    Ming Tatt Lee; Yu-Cheng Ho; Chau Ling Tham et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: The present study investigated the local analgesic effect of a novel synthetic cyclohexanone derivative, 2,6-bis-4-(hydroxyl-3-methoxybenzilidine)-cyclohexanone, or BHMC, in a mouse model of peripheral nociception. Methods: Local administration of BHMC (0.5–60 µg/paw)…

  5. Journal Article Full text

    Thermosensitive Hydrogel for Controlled Delivery of PAD4 Inhibitor YJ-2 in Diabetic Wound Healing

    Kai Wang; Ayijiang Taledaohan; Liujia Chan et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background: Diabetic wound healing is hampered by persistent inflammation and excessive neutrophil extracellular traps (NET) formation. Peptidylarginine deiminase 4 (PAD4) is a key enzyme driving this pathology. This study developed a thermosensitive chitosan/β-glycerophosphate hydrogel for the…

  6. Journal Article Full text

    Formulation and Evaluation of Alginate-Based Hydrogel Membranes Loaded with Colistin for Effective Management of Multidrug-Resistant Wound Infections

    Nizar Muhammad; Syed Sikandar Shah; Ashfaq Ahmad Shah Bukhari et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background: Combating antimicrobial resistance and developing dressings that match all aspects of wound healing will always be challenging. Methods: In this study, hydrogel membranes composed of sodium alginate (SA), polyvinyl alcohol (PVA), and Pluronic-f-127 (F-127) loaded with colistin (C) were…

  7. Journal Article Full text

    Tropism Profiling of Lentiviral Vector Pseudotypes in Diverse Brain Tumor Models

    Johannes K. Andersen; Lars A. R. Ystaas; Rolf Bjerkvig et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background: Lentiviral vectors (LVs) show promise as gene therapy tools for brain tumors, but optimal envelope protein choices for different tumor types have not been determined. Methodology: This study evaluated three pseudotyped LV variants—VSV-GP, FuG-B2, and LCMV-GP—across diverse brain tumor…

  8. Journal Article Full text

    Pulmonary Delivery of Inhalable Sustained Release Nanocomposites Microparticles Encapsulating Osimertinib for Non-Small Cell Lung Cancer Therapy

    Iman M. Alfagih; Alanood Almurshedi; Basmah Aldosari et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objective: Osimertinib (OSI) is a third-generation tyrosine kinase inhibitor approved for non-small cell lung cancer (NSCLC) therapy. OSI is administered orally; this route limits the amount of OSI reaching the tumor in the lungs and is associated with serious systemic toxicity. This…

  9. Journal Article Full text

    Clinical Characteristics, Long-Term Pharmacokinetics, and Outcomes in Kidney Transplant Recipients from an African Tertiary Centre: A 10-Year Single-Centre Retrospective Review

    Sadiq Aliyu Hussaini; Caroline Dickens; Confidence Makgoro et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background: Kidney transplantation outcomes in resource-limited settings remain underreported. This 10-year retrospective review examined the clinical characteristics, long-term pharmacokinetics, and outcomes of kidney transplant recipients at a South African public hospital. Methods: Data from…

  10. Journal Article Full text

    Phthalimide Derivatives as Anti-Inflammatory Agents: In Silico COX-2 Targeting and In Vitro Inhibition of PGE2 Production

    Héctor M. Heras Martínez; Blanca Sánchez-Ramírez; Linda-Lucila Landeros-Martínez et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: The development of specific inhibitors for cyclooxygenase-2 (COX-2) is a challenge for public health. A series of 17 N-phthalimide hybrids was evaluated using a functional M06 meta-GGA hybrid in combination with a polarized 6-311G (d, p) basis set. The top three candidates…

  11. Journal Article Full text

    MHY498 Nanosuspensions for Improved Topical Drug Delivery: Understanding of Its Solubility Behavior in DEGME + Water Mixtures and Preparation of Nanosuspension Using Box–Behnken Design

    Eun-Sol Ha; Ha Nim Lee; Seon-Kwang Lee et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: MHY498, a tyrosinase inhibitor, exhibits poor water solubility, which limits its topical delivery. Despite the importance of solubility data in rational formulation design, comprehensive information on its solubility behavior in various solvents and across a range of…

  12. Journal Article Full text

    Impeding the NHEJ Pathway for Overcoming Radioresistance in the Context of Precision Radiotherapy of Cancer

    Dragoș Andrei Niculae; Radu Marian Șerban; Dana Niculae et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Non-homologous end joining (NHEJ) is a critical DNA double-strand break (DSB) repair pathway that operates throughout the cell cycle to maintain the genomic stability of the cell. Unlike homologous recombination (HR), NHEJ is capable of repairing DSBs without the need for a homologous template…

  13. Journal Article Full text

    Albumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics

    Bogusława Konopska; Janusz Sokołowski; Anna Woźniak et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Modern medicine requires effective, continuous, and safe therapies, which largely depend on the targeted delivery and activity of the drug. This goal can be achieved by designing drug delivery systems with improved pharmacokinetic properties and enhanced drug transport to the affected tissue. Human…

  14. Journal Article Full text

    Pharmaceutical Cocrystals in Drug-Delivery Technologies: Advances from Rational Design to Therapeutic Applications

    Marina Monserrat Marcos Valdez; Norma Rebeca Sperandeo; Maria Soledad Bueno et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Pharmaceutical cocrystals are a well-established class of solid-state forms that can modulate the solubility, dissolution, stability, and bioavailability of active pharmaceutical ingredients without altering their molecular identity. Although traditional oral formulations have demonstrated…

  15. Journal Article Full text

    Targeted Inhibition of Oncogenic microRNAs miR-21, miR-17, and miR-155 Suppresses Tumor Growth and Modulates Immune Response in Colorectal Cancer

    Olga Patutina; Aleksandra Sen’kova; Svetlana Miroshnichenko et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background and Objectives: Aggressive cancer development is characterized by rapid tumor growth and progressive immune dysfunction. Tumor-derived microRNAs (miRNAs) emerge as master regulators of both malignant transformation and immune evasion, making them promising therapeutic targets. Using the…

  16. Journal Article Full text

    Extemporaneous Formulations for Pediatric Patients: Global Necessities, Challenges and Opportunities

    Vinita Balakrishna Pai; Milap Chand Nahata

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Many commercially available medications are often unapproved or unavailable in suitable dosage forms for specific patient populations, particularly infants and children. This necessitates the use of extemporaneously compounded formulations to deliver individualized doses based on body weight or…

  17. Journal Article Full text

    Streamlined Radiosynthesis of [18F]Fluproxadine (AF78): An Unprotected Guanidine Precursor Enables Efficient One-Step, Automation-Ready Labeling for Clinical Use

    Xinyu Chen; Kaito Ohta; Hiroyuki Kimura et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: [18F]Fluproxadine (formerly [18F]AF78) is a PET radiotracer targeting the norepinephrine transporter (NET) with potential applications in cardiac, neurological, and oncological imaging. Its guanidine moiety, while essential for NET binding, presents major radiosynthetic…

  18. Journal Article Full text

    Cellular Allies Against Glioblastoma: Therapeutic Potential of Macrophages and Mesenchymal Stromal Cells

    Bruno Agustín Cesca; Kali Pellicer San Martin; Luis Exequiel Ibarra

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: Glioblastoma (GBM) remains the most aggressive primary brain tumor in adults, with limited therapeutic options and poor prognosis despite maximal surgery, radiotherapy, and chemotherapy. The complex and immunosuppressive tumor microenvironment, pronounced intratumoral…

  19. Journal Article Full text

    Menthol-Based Cream as a Novel Therapy for Diabetic Skin Wounds

    Ana Júlia Vieira; Fernando Pereira Beserra; Gabriel Bacil Prata et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: Diabetes mellitus impairs skin wound healing by promoting a chronic inflammatory response and increased oxidative stress. This study aimed to investigate the healing potential of menthol in skin wounds of diabetic rats. Methods: A single dose of streptozotocin (50 mg/kg…

  20. Journal Article Full text

    Extracellular Vesicles from Probiotic and Beneficial Escherichia coli Strains Exert Multifaceted Protective Effects Against Rotavirus Infection in Intestinal Epithelial Cells

    Cecilia Cordero; Aitor Caballero-Román; Sergio Martínez-Ruiz et al.

    Pharmaceutics, Vol. 18 No. 1 · 2026 · English · DOAJ Scopus

    Background/Objectives: Rotavirus remains a major cause of severe acute gastroenteritis in infants worldwide. The suboptimal efficacy of current vaccines underscores the need for alternative microbiome-based interventions, including postbiotics. Extracellular vesicles (EVs) from probiotic and…

Showing at most 50 pages. Narrow your search with filters for more specific results.